HEADER COMPLEX(SERINE PROTEINASE-INHIBITOR) 05-SEP-88 2SEC TITLE STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN INHIBITOR TITLE 2 COMPLEXES. EGLIN-C-SUBTILISIN CARLSBERG AND CI-2-SUBTILISIN NOVO COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUBTILISIN CARLSBERG; COMPND 3 CHAIN: E; COMPND 4 EC: 3.4.21.62; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: EGLIN C; COMPND 8 CHAIN: I; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS LICHENIFORMIS; SOURCE 3 ORGANISM_TAXID: 1402; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 6 ORGANISM_COMMON: MEDICINAL LEECH; SOURCE 7 ORGANISM_TAXID: 6421; SOURCE 8 EXPRESSION_SYSTEM: UNIDENTIFIED; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 32644 KEYWDS COMPLEX(SERINE PROTEINASE-INHIBITOR) EXPDTA X-RAY DIFFRACTION AUTHOR C.A.MCPHALEN,M.N.G.JAMES REVDAT 8 21-FEB-24 2SEC 1 REMARK SEQADV LINK REVDAT 7 29-NOV-17 2SEC 1 HELIX REVDAT 6 24-FEB-09 2SEC 1 VERSN REVDAT 5 01-APR-03 2SEC 1 JRNL REVDAT 4 15-JAN-95 2SEC 1 COMPND REVDAT 3 15-OCT-89 2SEC 1 SEQRES REVDAT 2 19-APR-89 2SEC 1 JRNL REVDAT 1 07-SEP-88 2SEC 0 SPRSDE 07-SEP-88 2SEC 1SEC JRNL AUTH C.A.MCPHALEN,M.N.JAMES JRNL TITL STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN JRNL TITL 2 INHIBITOR COMPLEXES: EGLIN-C-SUBTILISIN CARLSBERG AND JRNL TITL 3 CI-2-SUBTILISIN NOVO. JRNL REF BIOCHEMISTRY V. 27 6582 1988 JRNL REFN ISSN 0006-2960 JRNL PMID 3064813 JRNL DOI 10.1021/BI00417A058 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.A.MCPHALEN,H.P.SCHNEBLI,M.N.G.JAMES REMARK 1 TITL CRYSTAL AND MOLECULAR STRUCTURE OF THE INHIBITOR EGLIN FROM REMARK 1 TITL 2 LEECHES IN COMPLEX WITH SUBTILISIN CARLSBERG REMARK 1 REF FEBS LETT. V. 188 55 1985 REMARK 1 REFN ISSN 0014-5793 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 27094 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.136 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2450 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 3 REMARK 3 SOLVENT ATOMS : 170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.009 ; 0.008 REMARK 3 ANGLE DISTANCE (A) : 0.027 ; 0.016 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.031 ; 0.016 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.017 ; 0.012 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.146 ; 0.080 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2SEC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178621. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR I 15 REMARK 465 GLU I 16 REMARK 465 PHE I 17 REMARK 465 GLY I 18 REMARK 465 SER I 19 REMARK 465 GLU I 20 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU E 112 CD GLU E 112 OE2 0.068 REMARK 500 GLU E 271 CD GLU E 271 OE2 0.069 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP E 14 CB - CG - OD1 ANGL. DEV. = 7.6 DEGREES REMARK 500 ASP E 14 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ASP E 41 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG E 145 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG E 249 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN E 25 -0.47 74.52 REMARK 500 ASP E 32 -148.84 -161.18 REMARK 500 ALA E 73 25.13 -142.80 REMARK 500 ASN E 77 -148.74 -152.56 REMARK 500 ASP E 181 -169.74 -107.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA E 276 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN E 2 OE1 REMARK 620 2 ASP E 41 OD1 151.3 REMARK 620 3 ASP E 41 OD2 156.2 52.4 REMARK 620 4 LEU E 75 O 78.9 88.4 110.5 REMARK 620 5 ASN E 77 ND2 74.4 79.7 126.0 88.8 REMARK 620 6 THR E 79 O 89.2 96.5 85.2 162.9 76.1 REMARK 620 7 VAL E 81 O 79.7 125.7 79.0 87.5 154.1 102.7 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA E 278 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ALA E 37 O REMARK 620 2 HIS E 39 O 88.8 REMARK 620 3 LEU E 42 O 100.8 76.3 REMARK 620 4 HOH E 373 O 55.9 129.9 77.1 REMARK 620 5 HOH E 463 O 171.0 85.8 70.9 123.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA E 277 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ALA E 169 O REMARK 620 2 TYR E 171 O 88.1 REMARK 620 3 VAL E 174 O 96.0 79.8 REMARK 620 4 HOH E 361 O 108.8 152.3 76.9 REMARK 620 5 HOH E 430 O 129.9 93.0 133.5 92.4 REMARK 620 N 1 2 3 4 REMARK 700 REMARK 700 SHEET REMARK 700 THE CROSS-OVER CONNECTION BETWEEN STRANDS 1 AND 2 OF SHEET REMARK 700 S1E IS LEFT-HANDED. REMARK 700 THE BETA-SHEET OF THE INHIBITOR IS IRREGULAR, WITH REMARK 700 WELL-ORDERED WATER MOLECULES PROVIDING ALL HYDROGEN-BONDING REMARK 700 BRIDGES BETWEEN STRANDS 2 AND 3. SEE THE REFERENCE CITED REMARK 700 ON THE *JRNL* RECORDS ABOVE. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: catalytic site REMARK 800 REMARK 800 SITE_IDENTIFIER: IO1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ion binding site REMARK 800 REMARK 800 SITE_IDENTIFIER: IO2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ion binding site REMARK 800 REMARK 800 SITE_IDENTIFIER: IO3 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ion binding site REMARK 800 REMARK 800 SITE_IDENTIFIER: RSB REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: inhibitor reactive site REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA E 276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA E 277 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA E 278 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SUBTILISIN HAS BEEN ASSIGNED CHAIN IDENTIFIER *E* AND EGLIN REMARK 999 C HAS BEEN ASSIGNED CHAIN IDENTIFIER *I*. THE AMINO ACID REMARK 999 SEQUENCE NUMBERING USED FOR EGLIN C IS BASED ON A SEQUENCE REMARK 999 ALIGNMENT WITH CHYMOTRYPSIN INHIBITOR 2 (CI-2) AND USES THE REMARK 999 CI-2 NUMBERING SCHEME. REMARK 999 REMARK 999 THE STRUCTURE OF SUBTILISIN CARLSBERG WAS REFINED ON THE REMARK 999 BASIS OF THE PUBLISHED AMINO ACID SEQUENCE OF THE PROTEIN REMARK 999 (E.L.SMITH ET AL., J. BIOL. CHEM., V. 243, P. 2184, 1968). REMARK 999 THE DNA SEQUENCE OF A CARLSBERG-LIKE ENZYME FROM BACILLUS REMARK 999 LICHENIFORMIS (JACOBS ET AL., NUCLEIC ACIDS RES., V. 13, REMARK 999 P. 8913, 1985) DIFFERS FROM THE ORIGINAL AMINO ACID REMARK 999 SEQUENCE OF SUBTILISIN CARLSBERG AT FIVE POSITIONS - REMARK 999 REMARK 999 SMITH JACOBS REMARK 999 SER E 103 THR E 103 REMARK 999 ALA E 129 PRO E 129 REMARK 999 ASN E 158 SER E 158 REMARK 999 SER E 161 ASN E 161 REMARK 999 ASN E 212 SER E 212 REMARK 999 REMARK 999 THE ELECTRON DENSITY AT POSITION 158 COULD BE CONSISTENT REMARK 999 WITH THE DNA SEQUENCE. THE DENSITY AT THE OTHER FOUR REMARK 999 POSITIONS IS CONSISTENT WITH THE RESULTS OF THE PROTEIN REMARK 999 SEQUENCING. DBREF 2SEC E 1 275 UNP P00780 SUBT_BACLI 106 379 DBREF 2SEC I 15 83 UNP P01051 ICIC_HIRME 1 70 SEQADV 2SEC SER E 103 UNP P00780 THR 207 CONFLICT SEQADV 2SEC ALA E 129 UNP P00780 PRO 233 CONFLICT SEQADV 2SEC ASN E 158 UNP P00780 SER 262 CONFLICT SEQADV 2SEC SER E 161 UNP P00780 ASN 265 CONFLICT SEQADV 2SEC ASN E 212 UNP P00780 SER 316 CONFLICT SEQADV 2SEC ASN I 47 UNP P01051 ASP 33 CONFLICT SEQRES 1 E 274 ALA GLN THR VAL PRO TYR GLY ILE PRO LEU ILE LYS ALA SEQRES 2 E 274 ASP LYS VAL GLN ALA GLN GLY PHE LYS GLY ALA ASN VAL SEQRES 3 E 274 LYS VAL ALA VAL LEU ASP THR GLY ILE GLN ALA SER HIS SEQRES 4 E 274 PRO ASP LEU ASN VAL VAL GLY GLY ALA SER PHE VAL ALA SEQRES 5 E 274 GLY GLU ALA TYR ASN THR ASP GLY ASN GLY HIS GLY THR SEQRES 6 E 274 HIS VAL ALA GLY THR VAL ALA ALA LEU ASP ASN THR THR SEQRES 7 E 274 GLY VAL LEU GLY VAL ALA PRO SER VAL SER LEU TYR ALA SEQRES 8 E 274 VAL LYS VAL LEU ASN SER SER GLY SER GLY SER TYR SER SEQRES 9 E 274 GLY ILE VAL SER GLY ILE GLU TRP ALA THR THR ASN GLY SEQRES 10 E 274 MET ASP VAL ILE ASN MET SER LEU GLY GLY ALA SER GLY SEQRES 11 E 274 SER THR ALA MET LYS GLN ALA VAL ASP ASN ALA TYR ALA SEQRES 12 E 274 ARG GLY VAL VAL VAL VAL ALA ALA ALA GLY ASN SER GLY SEQRES 13 E 274 ASN SER GLY SER THR ASN THR ILE GLY TYR PRO ALA LYS SEQRES 14 E 274 TYR ASP SER VAL ILE ALA VAL GLY ALA VAL ASP SER ASN SEQRES 15 E 274 SER ASN ARG ALA SER PHE SER SER VAL GLY ALA GLU LEU SEQRES 16 E 274 GLU VAL MET ALA PRO GLY ALA GLY VAL TYR SER THR TYR SEQRES 17 E 274 PRO THR ASN THR TYR ALA THR LEU ASN GLY THR SER MET SEQRES 18 E 274 ALA SER PRO HIS VAL ALA GLY ALA ALA ALA LEU ILE LEU SEQRES 19 E 274 SER LYS HIS PRO ASN LEU SER ALA SER GLN VAL ARG ASN SEQRES 20 E 274 ARG LEU SER SER THR ALA THR TYR LEU GLY SER SER PHE SEQRES 21 E 274 TYR TYR GLY LYS GLY LEU ILE ASN VAL GLU ALA ALA ALA SEQRES 22 E 274 GLN SEQRES 1 I 70 THR GLU PHE GLY SER GLU LEU LYS SER PHE PRO GLU VAL SEQRES 2 I 70 VAL GLY LYS THR VAL ASP GLN ALA ARG GLU TYR PHE THR SEQRES 3 I 70 LEU HIS TYR PRO GLN TYR ASN VAL TYR PHE LEU PRO GLU SEQRES 4 I 70 GLY SER PRO VAL THR LEU ASP LEU ARG TYR ASN ARG VAL SEQRES 5 I 70 ARG VAL PHE TYR ASN PRO GLY THR ASN VAL VAL ASN HIS SEQRES 6 I 70 VAL PRO HIS VAL GLY HET CA E 276 1 HET CA E 277 1 HET CA E 278 1 HETNAM CA CALCIUM ION FORMUL 3 CA 3(CA 2+) FORMUL 6 HOH *170(H2 O) HELIX 1 EA TYR E 6 ILE E 11 1 6 HELIX 2 EB ALA E 13 ALA E 18 1 6 HELIX 3 EC GLY E 63 ALA E 74 1 12 HELIX 4 ED SER E 103 ASN E 117 1 15 HELIX 5 EE SER E 132 ARG E 145 1 14 HELIX 6 EF THR E 220 HIS E 238 1INTERRUPTED BY PRO 225 19 HELIX 7 EG SER E 242 SER E 252 1 11 HELIX 8 EH SER E 259 GLY E 264 1 6 HELIX 9 EI ASN E 269 ALA E 274 1 6 HELIX 10 IA THR I 31 TYR I 43 1 13 SHEET 1 S1E 7 GLY E 46 PHE E 50 0 SHEET 2 S1E 7 SER E 89 VAL E 95 1 N ALA E 92 O GLY E 46 SHEET 3 S1E 7 VAL E 26 ASP E 32 1 N ASP E 32 O VAL E 93 SHEET 4 S1E 7 ASP E 120 MET E 124 1 O VAL E 121 N ALA E 29 SHEET 5 S1E 7 VAL E 148 ALA E 153 1 O VAL E 148 N ILE E 122 SHEET 6 S1E 7 ILE E 175 VAL E 180 1 N ILE E 175 O VAL E 149 SHEET 7 S1E 7 VAL E 198 GLY E 202 1 O VAL E 198 N GLY E 178 SHEET 1 S2E 2 VAL E 205 TYR E 209 0 SHEET 2 S2E 2 THR E 213 LEU E 217 -1 O LEU E 217 N VAL E 205 SHEET 1 S1I 4 LYS I 22 PHE I 24 0 SHEET 2 S1I 4 PRO I 80 VAL I 82 -1 N VAL I 82 O LYS I 22 SHEET 3 S1I 4 ASN I 64 TYR I 70 -1 SHEET 4 S1I 4 ASN I 47 GLU I 53 1 N ASN I 47 O ASN I 64 LINK OE1 GLN E 2 CA CA E 276 1555 1555 2.39 LINK O ALA E 37 CA CA E 278 1555 1555 2.81 LINK O HIS E 39 CA CA E 278 1555 1555 2.64 LINK OD1 ASP E 41 CA CA E 276 1555 1555 2.35 LINK OD2 ASP E 41 CA CA E 276 1555 1555 2.55 LINK O LEU E 42 CA CA E 278 1555 1555 2.58 LINK O LEU E 75 CA CA E 276 1555 1555 2.23 LINK ND2 ASN E 77 CA CA E 276 1555 1555 2.37 LINK O THR E 79 CA CA E 276 1555 1555 2.41 LINK O VAL E 81 CA CA E 276 1555 1555 2.28 LINK O ALA E 169 CA CA E 277 1555 1555 2.57 LINK O TYR E 171 CA CA E 277 1555 1555 2.57 LINK O VAL E 174 CA CA E 277 1555 1555 2.54 LINK CA CA E 277 O HOH E 361 1555 1555 2.59 LINK CA CA E 277 O HOH E 430 1555 1555 2.53 LINK CA CA E 278 O HOH E 373 1555 1555 3.17 LINK CA CA E 278 O HOH E 463 1555 1555 3.06 CISPEP 1 TYR E 167 PRO E 168 0 8.40 CISPEP 2 PRO E 210 THR E 211 0 -5.16 SITE 1 ACT 3 ASP E 32 HIS E 64 SER E 221 SITE 1 IO1 6 GLN E 2 ASP E 41 LEU E 75 ASN E 77 SITE 2 IO1 6 THR E 79 VAL E 81 SITE 1 IO2 5 ALA E 169 TYR E 171 VAL E 174 HOH E 361 SITE 2 IO2 5 HOH E 430 SITE 1 IO3 5 ALA E 37 HIS E 39 LEU E 42 HOH E 373 SITE 2 IO3 5 HOH E 463 SITE 1 RSB 2 LEU I 59 ASP I 60 SITE 1 AC1 6 GLN E 2 ASP E 41 LEU E 75 ASN E 77 SITE 2 AC1 6 THR E 79 VAL E 81 SITE 1 AC2 5 ALA E 169 TYR E 171 VAL E 174 HOH E 361 SITE 2 AC2 5 HOH E 430 SITE 1 AC3 3 ALA E 37 HIS E 39 LEU E 42 CRYST1 38.310 41.410 56.500 69.51 83.67 75.32 P 1 1 ORIGX1 0.026103 -0.006838 -0.000642 0.00000 ORIGX2 0.000000 0.024964 -0.008876 0.00000 ORIGX3 0.000000 0.000000 0.018900 0.00000 SCALE1 0.026103 -0.006838 -0.000642 0.00000 SCALE2 0.000000 0.024964 -0.008876 0.00000 SCALE3 0.000000 0.000000 0.018900 0.00000